Inventor · disambiguated record
Ehesan Ul Sharif
Also filed as: SHARIF EHESAN · SHARIF EHESAN U I · Sharif Ehesan Ul
12 granted patents·5 pending applications·71 citations·filing 2017–2024
89Inventor score
Files withARCUS BIOSCIENCES INC17
Top patents by PatentIndex Score
17 records- 0198US11001603B2Modulators of 5′-nucleotidase, ecto and the use thereofARCUS BIOSCIENCES INC·Filed 2020·Granted May 11, 2021·13 cites·1 claims
- 0296US10239912B2Modulators of 5′-nucleotidase, ecto and the use thereofARCUS BIOSCIENCES INC·Filed 2017·Granted Mar 26, 2019·23 cites·47 claims
- 0395US10981944B2Modulators of 5′-nucleotidase, ecto and the use thereofARCUS BIOSCIENCES INC·Filed 2019·Granted Apr 20, 2021·11 cites·20 claims
- 0494US12168023B2Inhibitors of adenosine 5′-nucleotidaseARCUS BIOSCIENCES INC·Filed 2024·Granted Dec 17, 2024·1 cites·24 claims
- 0592US10399962B2Azolopyrimidine for the treatment of cancer-related disordersARCUS BIOSCIENCES INC·Filed 2018·Granted Sep 3, 2019·13 cites·25 claims
- 0688US12195447B2Azolopyrimidine for the treatment of cancer-related disordersARCUS BIOSCIENCES INC·Filed 2021·Granted Jan 14, 2025·1 cites·2 claims
- 0787US11072597B2Azolopyrimidine for the treatment of cancer-related disordersARCUS BIOSCIENCES INC·Filed 2019·Granted Jul 27, 2021·3 cites·14 claims
- 0885US11058704B2Inhibitors of adenosine 5′-nucleotidaseARCUS BIOSCIENCES INC·Filed 2017·Granted Jul 13, 2021·4 cites·25 claims
- 0983US2025319113A1Inhibitors of adenosine 5'-nucleotidaseARCUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1079US11267845B2Inhibitors of CD73-mediated immunosuppressionARCUS BIOSCIENCES INC·Filed 2017·Granted Mar 8, 2022·1 cites·32 claims
- 1179US11045472B2Quinazoline-pyridine derivatives for the treatment of cancer-related disordersARCUS BIOSCIENCES INC·Filed 2018·Granted Jun 29, 2021·1 cites·20 claims
- 1257US2024124490A1Inhibitors of hpk1 and methods of use thereofARCUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1354US2024226115A1Axl inhibitor compoundsARCUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1453US2024246967A1Axl compoundsARCUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1551US2022235031A1Processes for preparing aminopyrimidine compoundsARCUS BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1648US12064433B2Pyridone A2R antagonistsARCUS BIOSCIENCES INC·Filed 2019·Granted Aug 20, 2024·0 cites·25 claims
- 1744US11220492B2Quinazoline-pyrazole derivatives for the treatment of cancer-related disordersARCUS BIOSCIENCES INC·Filed 2018·Granted Jan 11, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Ehesan Ul Sharif files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →